Alphabet subsidiary GV was part of a consortium in a round that will fund the progress of the precision medicine developer’s lead drug candidate into the clinic.
Month: March 2021
Skeleton Technologies powers up with $61m
The Harju Elekter-backed ultracapacitor producer will develop automated production technology with funding secured from the German government.
Terminus turns to Alibaba in series A round
Alibaba Cloud’s stake in the digitalisation technology provider now stands at over 31% following the latter’s $61.5m series A round.
Biocon buys a $40m piece of Bicara
The biopharmaceutical company has provided $40m in seed capital for the newly launched immuno-oncology drug developer.
Corporate venturing continues strong in February
Monthly analysis: February
A shining beacon in the dark
Where do you begin to summarise a year that has been the most challenging on a global scale in living memory?
What 500 Startups sees in emerging ecosystems
Comment from Bedy Yang, managing partner and head of ecosystems, 500vc, and Ee-Ling Lim, regional director for Asia-Pacific
How to bypass the usual operational pitfalls of CVC
Comment from Carol Strobel, operating partner, Redpoint eVentures, Brazil
How to make the right long-term bets on innovation at a time of rapid change
Comment from Vanessa Colella, chief innovation officer, Citi, and David Kidder, co-founder and CEO, Bionic
Cuorips captures coprorate funding
Osaka spinout Cuorips has added $14.7m to its coffers from investors including CellSource and Fujifilm, just three months after collecting $19.3m.
Best practices in corporate venture capital
Comment from Amy Burr, managing director, JetBlue Technology Ventures
Innovation and digitisation mean healthcare is at a tipping point
Feature: artificial intelligence driving disease prevention, digital health enables personalised medicine, investment takes off
Industrials survive the pandemic
Sector analysis: Industrial
Miller joins NPC Ventures to lead fundraising
Natural Products Canada has signed up a prospective anchor investor for its newly formed corporate venturing fund, which has a $39.5m target for its close.